Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Table S2 from Pertuzumab Enhances the Antitumor Activity of T-DXd in HER2-Positive Gastric Cancer Cells
  1. Home
  2. Publications
  3. Table S2 from Pertuzumab Enhances the Antitumor Activity of T-DXd in HER2-Positive Gastric Cancer Cells

Table S2 from Pertuzumab Enhances the Antitumor Activity of T-DXd in HER2-Positive Gastric Cancer Cells

Authors:
  • MKMinsu Kang
    Minsu Kang
  • KKKui-Jin Kim
    Kui-Jin Kim
  • HOHyeon Jeong Oh
    Hyeon Jeong Oh
  • JSJi Hea Sung
    Ji Hea Sung
  • MNMilang Nam
    Milang Nam
  • BPBo-Ram Park
    Bo-Ram Park
  • SHSung-Hyun Hwang
    Sung-Hyun Hwang
  • EJEun Hee Jung
    Eun Hee Jung
  • KSKoung Jin Suh
    Koung Jin Suh
  • JKJi-Won Kim
    Ji-Won Kim
  • SKSe Hyun Kim
    Se Hyun Kim
  • JKJin Won Kim
    Jin Won Kim

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.32709278
Abstract
No abstract available
Keywords
  • DRUG TARGETS
  • CELL SURFACE RECEPTOR DRUG TARGETS
  • GASTROINTESTINAL CANCERS
  • STOMACH CANCER
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.